In a new study published on March 7, 2017 by PLoS One, a team of researchers from the Graduate Institute of Clinical Medical Science in Taiwain, led by principal investigator Ji-An Liang, MD, found that the hepatitis C virus (HCV) increases cataract risk, particularly if treated with interferon-ribavirin. [Read more…]